Literature DB >> 3511475

Insulin-like growth factor I/somatomedin C: a potent inducer of oligodendrocyte development.

F A McMorris, T M Smith, S DeSalvo, R W Furlanetto.   

Abstract

Cell cultures established from cerebrum of 1-day-old rats were used to investigate hormonal regulation of the development of oligodendrocytes, which synthesize myelin in the central nervous system. The number of oligodendrocytes that developed was preferentially increased by insulin, or by insulin-like growth factor I (IGF-I), also known as somatomedin C. High concentrations (5 micrograms/ml) of insulin were required for substantial induction of oligodendrocyte development, whereas only 3.3 ng of IGF-I per ml was needed for a 2-fold increase in oligodendrocyte numbers. At an IGF-I concentration of 100 ng/ml, oligodendrocyte numbers were increased 6-fold in cultures grown in the presence of 10% fetal bovine serum, or up to 60-fold in cultures maintained in serum-free medium. IGF-I produced less than a 2-fold increase in the number of nonoligodendroglial cells in the same cultures. Type I IGF receptors were identified on oligodendrocytes and on a putative oligodendrocyte precursor cell population identified by using mouse monoclonal antibody A2B5. These results indicate that IGF-I is a potent inducer of oligodendrocyte development and suggest a possible mechanism based on IGF deficiency for the hypomyelination that results from early postnatal malnutrition.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3511475      PMCID: PMC322957          DOI: 10.1073/pnas.83.3.822

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Galactocerebroside is a specific cell-surface antigenic marker for oligodendrocytes in culture.

Authors:  M C Raff; R Mirsky; K L Fields; R P Lisak; S H Dorfman; D H Silberberg; N A Gregson; S Leibowitz; M C Kennedy
Journal:  Nature       Date:  1978-08-24       Impact factor: 49.962

Review 2.  Nutritional regulation of somatomedin.

Authors:  L S Phillips; R Vassilopoulou-Sellin
Journal:  Am J Clin Nutr       Date:  1979-05       Impact factor: 7.045

Review 3.  Hormonal regulation of growth by somatomedin and other tissue growth factors.

Authors:  W H Daughaday
Journal:  Clin Endocrinol Metab       Date:  1977-03

4.  Experimental allergic neuritis induced by sensitization with galactocerebroside.

Authors:  T Saida; K Saida; S H Dorfman; D H Silberberg; A J Sumner; M C Manning; R P Lisak; M J Brown
Journal:  Science       Date:  1979-06-08       Impact factor: 47.728

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Nutrition and somatomedin. I. Effect of fasting and refeeding on serum somatomedin activity and cartilage growth activity in rats.

Authors:  L S Phillips; H S Young
Journal:  Endocrinology       Date:  1976-07       Impact factor: 4.736

Review 7.  Somatomedins (first of two parts).

Authors:  L S Phillips; R Vassilopoulou-Sellin
Journal:  N Engl J Med       Date:  1980-02-14       Impact factor: 91.245

Review 8.  Somatomedins (second of two parts).

Authors:  L S Phillips; R Vassilopoulou-Sellin
Journal:  N Engl J Med       Date:  1980-02-21       Impact factor: 91.245

9.  Monoclonal antibody to a plasma membrane antigen of neurons.

Authors:  G S Eisenbarth; F S Walsh; M Nirenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

10.  Effects of immunologically induced growth hormone deficiency on myelinogenesis in developing rat cerebrum.

Authors:  E W Pelton; R E Grindeland; E Young; N H Bass
Journal:  Neurology       Date:  1977-03       Impact factor: 9.910

View more
  63 in total

1.  Growth hormone levels in relation to birth weight and gestational age.

Authors:  G D Rajesh; B V Bhat; M G Sridhar; P Ranganathan
Journal:  Indian J Pediatr       Date:  2000-03       Impact factor: 1.967

Review 2.  Neuronal cell cultures: a tool for investigations in developmental neurobiology.

Authors:  A Cestelli; G Savettieri; G Salemi; I Di Liegro
Journal:  Neurochem Res       Date:  1992-12       Impact factor: 3.996

Review 3.  Neurodevelopmental effects of insulin-like growth factor signaling.

Authors:  John O'Kusky; Ping Ye
Journal:  Front Neuroendocrinol       Date:  2012-06-16       Impact factor: 8.606

Review 4.  Molecular biology of the insulin-like growth factors. Relevance to nervous system function.

Authors:  J E Hepler; P K Lund
Journal:  Mol Neurobiol       Date:  1990 Spring-Summer       Impact factor: 5.590

Review 5.  Oligodendrocyte Development and Plasticity.

Authors:  Dwight E Bergles; William D Richardson
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-08-20       Impact factor: 10.005

6.  Anti-reovirus receptor antibody accelerates expression of the optic nerve oligodendrocyte developmental program.

Authors:  J A Cohen; W V Williams; H M Geller; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

Review 7.  The insulin-like growth factor system and the fetal brain: effects of poor maternal nutrition.

Authors:  Thomas J McDonald; Mark J Nijland; Peter W Nathanielsz
Journal:  Rev Endocr Metab Disord       Date:  2007-06       Impact factor: 6.514

Review 8.  Insulin and insulin-like growth factor receptors in the nervous system.

Authors:  M Adamo; M K Raizada; D LeRoith
Journal:  Mol Neurobiol       Date:  1989 Spring-Summer       Impact factor: 5.590

9.  Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis.

Authors:  D L Yao; X Liu; L D Hudson; H D Webster
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

10.  Insulin-like growth factor (IGF)-I, -II and IGF-binding proteins in the cyst fluid of a patient with astrocytoma.

Authors:  W Zumkeller; M Sääf; T Rähn
Journal:  Childs Nerv Syst       Date:  1993-04       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.